Barclays’s Foundation Medicine, Inc. FMI Stock Holding History

Barclays’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-132,500	Closed	-$18.1M	–	7656
2018 Q2	$18.1M	Buy	132,500 +130,500	+6,525%	+$11.9M	0.02%	841
2018 Q1	$158K	Sell	2,000 -1,100	-35%	-$81.2K	﹤0.01%	5035
2017 Q4	$211K	Buy	+3,100	New	+$161K	﹤0.01%	4653
2015 Q3	–	Sell	-50,000	Closed	-$1.65M	–	7209
2015 Q2	$1.65M	Sell	50,000 -117,000	-70%	-$4.71M	﹤0.01%	2403
2015 Q1	$8.02M	Buy	+167,000	New	+$7.58M	0.01%	1226
2014 Q3	–	Sell	-50,000	Closed	-$1.3M	–	7940
2014 Q2	$1.3M	Buy	+50,000	New	+$1.27M	﹤0.01%	3066

Barclays's FMI Position: Q3 2018 in Review

Barclays sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 19,628 shares — an estimated $2.68M sold.

Barclays first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $2.68M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

Barclays reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
Barclays sold 19,628 Foundation Medicine, Inc. shares in Q3 2018, an estimated $2.68M.
Barclays first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
Barclays's Foundation Medicine, Inc. position peaked at $2.68M in Q2 2018.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.